Wealth Enhancement Advisory Services, LLC Repligen Corp Transaction History
Wealth Enhancement Advisory Services, LLC
- $49.5 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Repligen Corp stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 4,045 shares of RGEN stock, worth $514,685. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,045
Previous 4,009
0.9%
Holding current value
$514,685
Previous $577,000
0.87%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding RGEN
# of Institutions
483Shares Held
56.4MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$963 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$908 Million0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$649 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$215 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$196 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.06B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....